John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 42,876 shares at $9.55 ($409K) on 2024-03-26, disclosed to the SEC on 2024-03-26.
Open-market sale of $409k SERA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.55 | 21,438 | $205K | 50.0% |
| 2 | $9.55 | 21,438 | $205K | 50.0% |
| Total | $9.55 avg | 42,876 | $409K | 100% |
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |